Evidence map›Paper›PMID 40241688›Full record

ArticleFood science & nutrition2025

Formula Optimization for In Vitro Assessment of Nutritional, Sensory, and Bioactive Properties of Functional Bee Product Mixtures.

Melike Ağirsaygin, Müge Hendek Ertop

Abstract read
In one paragraph

Article in Food science & nutrition, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Melike AğirsayginInstitute of Science, Department of Food Engineering Kastamonu University Kastamonu Türkiye.ORCID https://orcid.org/0000-0003-3180-0556
Müge Hendek ErtopFaculty of Engineering and Architecture, Department of Food Engineering Kastamonu University Kastamonu Türkiye.ORCID https://orcid.org/0000-0003-4300-7790

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The bee products, whose rich bioactive and nutritional properties are supported by substantial scientific research, present significant and safe alternatives for today's consumers' daily diets. Considering the challenges today's individuals face in accessing safe and high-quality bee products, as well as their expectation for foods that are not only satiating but also functional, offering these products as a single mixture presents a promising alternative. This study aimed to develop a bee product mixture (BPM) by utilizing three primary bee products (two types of honey [multifloral and chestnut], bee-collected pollen, and propolis). The formulation was optimized using the response surface methodology, focusing on sensory acceptability and bioactive properties. The optimized levels for BPM with multifloral honey were determined as 1.73% propolis, 10.24% pollen, and 88.03% honey, and for BPM with chestnut honey, were determined as 4.07% propolis, 10.24% pollen, and 85.69% honey. Both BPMs were compared regarding physicochemical and bioactive properties, amino acid, and mineral compositions. They demonstrated significantly higher phenolic content, amino acid composition, and mineral profiles than the two types of honey used as raw materials (chestnut and multifloral honey). Although BPM with chestnut honey exhibited higher values, it was revealed that multifloral honey could be transformed into a nutritionally value-added product with the bee products incorporated in it. The pollen was found to be the primary bee product that determined the functional properties of BPM. While the study results, focused on the optimization and fundamental analysis of mixtures, provide general insights into their functionality, further advanced clinical studies are necessary to draw definitive conclusions regarding their apitherapeutic properties.

Indexed as

bee product mixturebioactivityoptimizationresponse surface methodology

Identifiers

PMID40241688
PMCPMC12000235

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.